Balance Sheet

v3.6.0.2
Consolidated Balance Sheets - USD ($)
Dec. 31, 2016
Dec. 31, 2015
Current assets:    
Cash and cash equivalents $ 3,979,290 $ 4,084,085
Grants receivable 0 757,562
Prepaid expenses 281,858 419,751
Other current assets 32,830 47,586
Total current assets 4,293,978 5,308,984
Property and equipment, net 731,712 135,486
Goodwill 6,826,003 6,826,003
Other long term assets 168,597 126,654
Total assets 12,020,290 12,397,127
Current liabilities:    
Accounts payable 1,137,903 3,002,497
Accrued compensation 770,592 562,755
Accrued clinical operations and site costs 1,218,641 391,041
Accrued lease contingency fee 590,504 590,504
Other accrued expenses 315,034 411,566
Interest payable 51,295 0
Current portion of notes payable 1,589,661 0
Current portion of capital leases payable 17,004 0
Total current liabilities 5,690,634 4,958,363
Long-term liabilities:    
Long-term portion of notes payable, net 2,774,627 0
Long-term portion of capital leases 68,113 0
Other long-term liabilities 144,394 0
Total long-term liabilities 2,987,134 0
Total liabilities 8,677,768 4,958,363
Commitments and contingencies
Stockholders' equity:    
Common stock, $0.01 par value; 150,000,000 shares authorized, 6,296,110 and 3,836,631 shares issued and outstanding as of December 31, 2016 and 2015, respectively 62,961 38,366
Additional paid-in capital 81,533,511 67,999,928
Accumulated deficit (78,262,261) (60,601,778)
Total stockholders' equity 3,342,522 7,438,764
Total liabilities and stockholders' equity 12,020,290 12,397,127
Series D Convertible Preferred Stock [Member]    
Stockholders' equity:    
Preferred stock 1,325 1,915
Series E Convertible Preferred Stock [Member]    
Stockholders' equity:    
Preferred stock 333 333
Series F Convertible Preferred Stock [Member]    
Stockholders' equity:    
Preferred stock $ 6,653 $ 0

Source